What is the approximate price per bottle of Mitotane that patients can afford?

Mitotane (Mitotane) is a special anti-tumor drug mainly used for the treatment of adrenocortical cancer. It is a long-term drug with gradually adjusted dosage. Its cost is often a practical factor that patients and their families focus on. Judging from the current situation, mitotane has an original drug on the market in China, but it has not yet been included in the medical insurance catalog. Therefore, the overall cost needs to be borne by the patient at his own expense, and the economic pressure is relatively obvious.

In the domestic market, the price of mitotane original drug is about 10,000 yuan per box, and the usual specifications are 500mg and 100 tablets. Since the drug often needs to be taken continuously for several months or even longer in clinical practice, and some patients need to gradually increase the dose, the actual cost of the drug may be much higher than the price of a single box. For ordinary families, this cost level places high demands on economic conditions.

In overseas markets, the original version of mitotane mainly includes the European version and the Turkish version. The common specifications are also 500mg and 100 tablets per box. The price is about 9,000 yuan. Affected by exchange rates, transportation and drug purchase channels, the actual transaction price may fluctuate to a certain extent. Compared with domestic original drugs, overseas original drugs have no obvious advantage in price, but they are still an option for some patients.

It is worth noting that there are already generic versions of mitotane on the market in overseas markets. For example, the generic version produced in Laos has the same specifications as the original version, and the price of each box may be around more than 2,000 yuan. This price has significantly reduced the financial burden on patients, making it easier for some long-term medication patients to afford it. However, regardless of whether they choose original or generic drugs, patients should take the drugs under the guidance of doctors and obtain drugs through relatively formal channels to take into account both affordability and drug safety.

Keyword tags: mitotane, adrenocortical cancer, price, generic drugs, economic burden

Reference:https://reference.medscape.com/drug/lysodren-mitotane-342258